The U. S. Food and Drug Administration (FDA) has issued a new drug label warning that the cholesterol drug Crestor has been linked to heart attacks, stroke, and death. The FDA’s new warning applies to Crestor and Valtrex, both of which are in a class of drugs called statins. Valtrex is the generic version of Crestor. (For a detailed list of drugs under review, see the FDA’s Drug Information section.)
The FDA has issued a similar warning, based on a study published in the May 2023 edition of theJournal of the American Medical Associationin which the FDA reviewed the evidence supporting the increased risk of heart attacks and stroke in patients taking statins. The FDA also issued a separate warning regarding the possible link to kidney cancer.
The FDA has added a warning regarding a rare cardiovascular event, including heart attack, that could increase the risk of death in patients taking statins. In a, the FDA issued a similar warning regarding a rare but potentially fatal heart attack that could increase the risk of death in patients taking statins.
“The FDA has made a significant progress in lowering the risk of cardiovascular events through the use of generic drugs. Although the FDA has made very substantial progress in lowering the risk of cardiovascular events, it is now time to put a stop to this slow and slow progress,” said Dr. Steven Nissen, an endocrinologist at New York University Hospital, New York City.
“In particular, we are moving away from the use of generic drugs in prescribing statins, which are often more expensive and harder to obtain, and toward the new, more effective use of generic drugs that include these statins. In particular, we are moving away from the use of generic drugs in prescribing statins, which are often more expensive and harder to obtain, and toward the new, more effective use of generic drugs that include these statins.”
The FDA also issued a warning to the public regarding the use of generic drugs with a new drug label that included warnings about possible heart attack and stroke risk increases in patients taking statins.in which the FDA reviewed the evidence supporting the increased risk of heart attack and stroke in patients taking statins.
In addition to the FDA warning about heart attack risk, the FDA issued a similar warning regarding kidney cancer, which has also been added to the label. According to the FDA, the risk of kidney cancer increases in patients who have already had kidney dialysis before taking statin therapy. The FDA also issued a similar warning regarding the increased risk of heart attack and stroke in patients taking statins, but the risk was not increased in patients who were given a statin prior to dialysis treatment. The FDA also issued a similar warning regarding the increased risk of stroke in patients who have a previous history of stroke.
The FDA has issued a new warning regarding the possible increased risk of heart attack in patients taking statins, but the FDA has issued a different warning to the public regarding the increased risk of stroke. The FDA’s new warning applies to statins and is based on a study published in the May 2023 edition of theThe FDA also issued a similar warning regarding the possible increased risk of kidney cancer, which has also been added to the label. The FDA has issued a similar warning regarding the increased risk of heart attack and stroke in patients taking statins, but the risk was not increased in patients who were given a statin prior to dialysis treatment.
The FDA has issued a warning regarding the increased risk of heart attack in patients taking statins, but the FDA has issued a different warning to the public regarding the increased risk of stroke.The FDA also issued a similar warning regarding the increased risk of kidney cancer, which has also been added to the label.
Medically reviewed by Jessica Swirble, PharmDLast updated on April 2, 2025
Drug Information| | |
|
| Interaction with AlcoholThe following drugs can increase the risk of QT interval prolongation. These include: atorvastatin (Lipitor), atorvastatin (Zidovud, Zydus Cadila), pravastatin (Vasco), and rosuvastatin (Crestor).
The Food and Drug Administration (FDA) has approved amiodarone for the treatment of. However, it is not approved for the treatment of, as it has not been shown to have an effect on cholesterol levels and has not been shown to cause side effects. A small number of individuals taking amiodarone have reported QT interval prolongation, as assessed by electrocardiograms. This risk may be higher in individuals with a history of QT prolongation, particularly if taking higher doses or concomitant medications. Amiodarone should not be used for the treatment of sudden cardiac death or QT prolongation in patients already at risk for such an event.
Clarithromycin is an antibiotic that has been shown to be effective against certain bacteria. Clarithromycin can interact with certain medications, particularly with alcohol. Clarithromycin is not approved for the treatment of, as it has not been shown to have an effect on cholesterol levels and has not been shown to cause side effects. Clarithromycin should not be used for the treatment of sudden cardiac death or QT prolongation in patients already at risk for such an event.
Clarithromycin and lithobid (Catapres) are both antibiotics that have been shown to interact with certain medications, particularly with alcohol.
Clarithromycin and minocycline are both antibiotics that have been shown to interact with certain medications, particularly with alcohol.
Clarithromycin and rifampin are both antibiotics that have been shown to interact with certain medications, particularly with alcohol.
CRESTOR 20MG TABLET is used in the management of high blood cholesterol levels. It is prescribed when diet and exercise does not result in adequate results. It contains a medicine called which is an anti-hyperlipidemic agent that works by blocking cholesterol production in the body. It also makes your body eliminate lipids particles from the blood.
By reducing blood cholesterol levels, this medicine is helpful is reducing cardiovascular risks and problems in blood circulation across the body. While taking CRESTOR 20MG TABLET, you must follow a cholesterol-lowering diet, lifestyle changes and regular physical activity as instructed by your doctor to achieve better results.
Before taking CRESTOR 20MG TABLET inform your doctor if you have any lung, liver, kidney or heart problems. You must also inform your doctor if you have diabetes, thyroid problems, or a family history of muscle disorders. Do not take CRESTOR 20MG TABLET if you are pregnant or breastfeeding without consulting your doctor.
CRESTOR 20MG TABLET may increase your blood sugar levels, especially in patients who are diabetic. It may also affect the way your liver works and so your doctor will closely monitor your blood sugar levels and liver functions while undergoing therapy with CRESTOR 20MG TABLET as a precaution.
The most common side effects of taking CRESTOR 20MG TABLET are muscle ache, constipation, stomach pain, dizziness, nausea and headache. Inform your doctor if you experience severe unexplained muscle pain, tenderness or weakness along with fever after taking CRESTOR 20MG TABLET.
How should I take CRESTOR 20MG TABLET? CRESTOR 20MG TABLET should be used with caution in patients with high cholesterol levels. Always follow your doctor’s instructions regarding doses and storage conditions of CRESTOR 20MG TABLET.The proper balance of blood sugar and cholesterol is crucial for optimal results from therapy with CRESTOR 20MG TABLET. To ensure your safety, continue taking CRESTOR 20MG TABLET with food, howevern you are taking it, avoid altering your diet or skipping doses if you finds no significant side effects.
What are the side effects of CRESTOR 20MG TABLET?It can cause symptoms such as dizziness, feeling sick, tiredness, difficulty sleeping, «uncontrolled muscle spasm created by CRESTOR 20MG TABLET (especially in patients with a history of heart attack or stroke),ectoris
you should mention to your doctor any latest side effect that you are managing.
patients with a history of heart problems (such as heart failure, heart bypass membrane disease, left ventricular hypertrophy, Left Ventimicrobialage).
This medication can cause problems in blood circulation, including bronchitis, pneumonia, leukaemia, multiple myeloma, and multiple sclerosis. Avoid risk factors and alcohol while taking this medication.
It can cause side effects in patients with liver, kidney or heart conditions. Some patients may experience side effects with CRESTOR 20MG TABLET such as headache, dizziness, nausea, and anorexia, diarrhea, and constipation.
Patients should be aware of the serious side effects and seek medical attention if they experience a muscle pain, tenderness or weakness along with movement.
Taking CRESTOR 20MG TABLET with any antacid or calcium-containing medications can cause serious side effects, so before taking these products, tell your doctor if you have diabetes, thyroid problems, kidney or liver disease, blood circulation problems, or a history of serious allergies or hereditary problems.
Taking CRESTOR 20MG TABLET with paracetamol and ibuprofen, as it reduces your blood sugar levels may also cause side effects, but the majority of these patients are managed effectively.
The patient should not take CRESTOR 20MG TABLET if they are pregnant or breastfeeding without consulting their doctor.
The patient should not take CRESTOR 20MG TABLET if they are having any permanent damage to the penis, as this medication can cause problems in blood circulation, including a prolonged painful erection (priapism), permanent discolouration of penis or potential irreversible permanent dysfunction of penis during and after sexual activity.
The patient should not take CRESTOR 20MG TABLET if they are having this condition, as it may affect their ability to have an erection.
Crestor, containing rosuvastatin, is a widely prescribed statin medication for the treatment of high cholesterol, high blood pressure, and certain types of triglycerides in the blood. It belongs to a class of drugs known as " statins..., " and is used to reduce cholesterol levels by increasing the production of cholesterol-making cholesterol-derived sterols, such as lSaharan and high-density lipoprotein (HDL-C)..
The global rosuvastatin market is experiencing significant growth, driven by several key factors. As of 2023, the market size was valued at USD 1.64 billion and is projected to reach USD 2.64 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 5.5% from 2024 to 2031[3].
The market is segmented into higher-risk markets, including:
The hospitalized patients in North America and South America are major payers of Crestor, with North America being the largest contributor. The retail sale of Crestorospitalized patients was estimated at $40.46 billion in 2022, growing at a CAGR of 3.80% from 2022 to 2031.
The patient-Nonsurgical patients in the market were estimated at $8.60 per day, with patients being seen in their 30s, 50s, and older due to surgical risks and availability of medical equipment and medical personnel[3].
The healthcare investments in the market were estimated at $55.94 billion in 2022, growing at a CAGR of 3.21% from 2022 to 2031.
The Asia Pacific region is expected to grow at a CAGR of 3.4% from 2023 to 2031 from a daily supply of $4.70 billion. The cost of Crestor in this region was estimated at $1.58 per day, with countries having high healthcare costs due to growing medical facilities and increasing healthcare expenditure[3].
These regions are also expected to grow at a CAGR of 4.6% and 5.3%, respectively, from 2023 to 2031 from a daily supply of $8.60 billion[3].
The Europe segment is driven by:
Stade de France Pharmacy